|
TSGA14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.829190E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.727400E-01 |
| Normal-vs-Stage2 |
7.255000E-01 |
| Normal-vs-Stage3 |
4.448300E-02 |
| Normal-vs-Stage4 |
4.048200E-02 |
| Stage1-vs-Stage2 |
2.807600E-01 |
| Stage1-vs-Stage3 |
1.256970E-01 |
| Stage1-vs-Stage4 |
9.540400E-02 |
| Stage2-vs-Stage3 |
5.736200E-02 |
| Stage2-vs-Stage4 |
5.372200E-02 |
| Stage3-vs-Stage4 |
6.440200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.841210E-01 |
| Normal-vs-AfricanAmerican |
3.081400E-01 |
| Normal-vs-Asian |
7.596000E-02 |
| Caucasian-vs-AfricanAmerican |
6.567600E-02 |
| Caucasian-vs-Asian |
3.716800E-01 |
| AfricanAmerican-vs-Asian |
2.174200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.779600E-03 |
| Normal-vs-Female |
6.401000E-01 |
| Male-vs-Female |
4.022300E-04 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.658800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.483000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.170180E-01 |
| Normal-vs-Age(81-100Yrs) |
2.559600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.673600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.935400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.005000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.367200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.100200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.097000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.601790E-02 |
| Classical-VS-Follicular |
5.671600E-02 |
| Classical-VS-Other |
8.400100E-02 |
| Classical-VS-Normal |
8.282600E-01 |
| Tall-VS-Follicular |
2.627200E-01 |
| Tall-VS-Other |
7.326800E-01 |
| Tall-VS-Normal |
8.422900E-03 |
| Follicular-VS-Other |
3.674000E-01 |
| Follicular-VS-Normal |
1.069950E-01 |
| Other-VS-Normal |
2.482600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.501000E-01 |
| Normal-vs-N1 |
3.293600E-02 |
| N0-vs-N1 |
1.233250E-01 |
|
|
